These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33933456)

  • 21. Millisecond Hydrogen/Deuterium-Exchange Mass Spectrometry for the Study of Alpha-Synuclein Structural Dynamics Under Physiological Conditions.
    Seetaloo N; Phillips JJ
    J Vis Exp; 2022 Jun; (184):. PubMed ID: 35815971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroanatomical and cognitive biomarkers of alpha-synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms.
    Tullo S; Miranda AS; Del Cid-Pellitero E; Lim MP; Gallino D; Attaran A; Patel R; Novikov V; Park M; Beraldo FH; Luo W; Shlaifer I; Durcan TM; Bussey TJ; Saksida LM; Fon EA; Prado VF; Prado MAM; Chakravarty MM
    J Neurochem; 2024 Aug; 168(8):1546-1564. PubMed ID: 37804203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.
    Villar-Piqué A; Lopes da Fonseca T; Sant'Anna R; Szegö ÉM; Fonseca-Ornelas L; Pinho R; Carija A; Gerhardt E; Masaracchia C; Abad Gonzalez E; Rossetti G; Carloni P; Fernández CO; Foguel D; Milosevic I; Zweckstetter M; Ventura S; Outeiro TF
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6506-E6515. PubMed ID: 27708160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of local reduction of endogenous α-synuclein using antisense oligonucleotides on the fibril-induced propagation of pathology through the neural network in wild-type mice.
    Sano T; Nagata T; Ebihara S; Yoshida-Tanaka K; Nakamura A; Sasaki A; Shimozawa A; Mochizuki H; Uchihara T; Hasegawa M; Yokota T
    Acta Neuropathol Commun; 2024 May; 12(1):75. PubMed ID: 38745295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein.
    Landeck N; Strathearn KE; Ysselstein D; Buck K; Dutta S; Banerjee S; Lv Z; Hulleman JD; Hindupur J; Lin LK; Padalkar S; Stanciu LA; Lyubchenko YL; Kirik D; Rochet JC
    Mol Neurodegener; 2020 Sep; 15(1):49. PubMed ID: 32900375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose.
    Hoffmann AC; Minakaki G; Menges S; Salvi R; Savitskiy S; Kazman A; Vicente Miranda H; Mielenz D; Klucken J; Winkler J; Xiang W
    Sci Rep; 2019 Jan; 9(1):544. PubMed ID: 30679445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast.
    Brás IC; Tenreiro S; Silva AM; Outeiro TF
    FEMS Yeast Res; 2018 Dec; 18(8):. PubMed ID: 30277516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight.
    Al-Azzani M; König A; Outeiro TF
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules.
    Hsieh CJ; Ferrie JJ; Xu K; Lee I; Graham TJA; Tu Z; Yu J; Dhavale D; Kotzbauer P; Petersson EJ; Mach RH
    ACS Chem Neurosci; 2018 Nov; 9(11):2521-2527. PubMed ID: 29750499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity.
    Vinueza-Gavilanes R; Íñigo-Marco I; Larrea L; Lasa M; Carte B; Santamaría E; Fernández-Irigoyen J; Bugallo R; Aragón T; Aldabe R; Arrasate M
    Neurobiol Dis; 2020 Apr; 137():104781. PubMed ID: 31991248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins.
    Vaneyck J; Segers-Nolten I; Broersen K; Claessens MMAE
    J Biol Chem; 2021; 296():100358. PubMed ID: 33539920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha synuclein processing by MMP-3 - implications for synucleinopathies.
    Bluhm A; Schrempel S; Moceri S; Stieler J; Feja M; Schilling S; Schulze A; von Hörsten S; Hartlage-Rübsamen M; Richter F; Roßner S
    Behav Brain Res; 2022 Sep; 434():114020. PubMed ID: 35870616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts.
    Strohäker T; Jung BC; Liou SH; Fernandez CO; Riedel D; Becker S; Halliday GM; Bennati M; Kim WS; Lee SJ; Zweckstetter M
    Nat Commun; 2019 Dec; 10(1):5535. PubMed ID: 31797870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
    Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
    Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay.
    Arlinghaus R; Iba M; Masliah E; Cookson MR; Landeck N
    J Parkinsons Dis; 2023; 13(2):255-270. PubMed ID: 36847016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic control in amyloid polymorphism: Different agitation and solution conditions promote distinct amyloid polymorphs of alpha-synuclein.
    Devi S; Garg DK; Bhat R
    Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140917. PubMed ID: 37061153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing the dynamics of α-synuclein oligomers using hydrogen/deuterium exchange monitored by mass spectrometry.
    Mysling S; Betzer C; Jensen PH; Jorgensen TJ
    Biochemistry; 2013 Dec; 52(51):9097-103. PubMed ID: 24191706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities.
    Alam P; Bousset L; Melki R; Otzen DE
    J Neurochem; 2019 Sep; 150(5):522-534. PubMed ID: 31254394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traffic jams and the complex role of α-Synuclein aggregation in Parkinson disease.
    Gonçalves SA; Outeiro TF
    Small GTPases; 2017 Apr; 8(2):78-84. PubMed ID: 27314512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives.
    Lázaro DF; Lee VM
    Neuron; 2024 Sep; 112(18):3029-3042. PubMed ID: 38861985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.